关于持股 5%以上股东权益变动触及 5%刻度的 提示性公告 股东宁波国富永钰创业投资合伙企业（有限合伙）保证向本公司提供的信息真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 本次权益变动为西安瑞联新材料股份有限公司（以下简称"瑞联新材" 或"公司"）股东履行减持股份计划所致，不触及要约收购。 本次权益变动前，公司持股 5%以上股东宁波国富永钰创业投资合伙企业 （有限合伙）（以下简称"国富永钰"）8,679,280 股股份，占公司总股本的 5.0003%。 2025 年 10 月 30 日，国富永钰通过集中竞价交易方式减持公司股份 514 股，占 公司总股本的 0.0003%，本次权益变动后，国富永钰持股 8,678,766 股，占公司 总股本的 5.0000%，权益变动触及 5%刻度。 证券代码：688550 证券简称：瑞联新材 公告编号：2025-091 西安瑞联新材料股份有限公司 （三）本次权益变动前后，信息披露义务人持有公司股份情况 | 股东名称 | 股份性质 | 持股数量 | 本次权益变动前 | 本次权益变动 ...

证券代码：688550 证券简称：瑞联新材 公告编号：2025-089 西安瑞联新材料股份有限公司 关于调整 2021 年限制性股票激励计划授予价格及作 废部分已授予尚未归属的限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本次限制性股票激励计划已履行的决策程序和信息披露情况 1、2021 年 9 月 29 日，公司召开第三届董事会 2021 年第一次临时会议，审 议通过了《关于<西安瑞联新材料股份有限公司 2021 年限制性股票激励计划（草 案）>及其摘要的议案》《关于<西安瑞联新材料股份有限公司 2021 年限制性股 票激励计划实施考核管理办法>的议案》以及《关于提请股东大会授权董事会办 理 2021 年限制性股票激励计划相关事宜的议案》。公司独立董事就本次激励计 划相关议案发表了明确同意的独立意见。 同日，公司召开第三届监事会 2021 年第一次临时会议，审议通过了《关于< 西安瑞联新材料股份有限公司 2021 年限制性股票激励计划（草案）>及其摘要的 议案》《关于<西安瑞联新材料股份有限公司 ...

2021 年限制性股票激励计划授予价格调整 北京市君泽君（上海）律师事务所 关于西安瑞联新材料股份有限公司 及作废部分已授予尚未归属的限制性股票相关事项 之 法律意见书 二零二五年十月 地址：上海市浦东新区杨高南路 729 号陆家嘴实际金融广场 1 号楼 4002 室 Address: Suite 4002, Tower 1, Lujiazui Century Financial Plaza, No.729 South Yanggao Road, Pudong New District, Shanghai 200127, P.R.C. 电话：(86 21) 61060889 传真(Fax)：(86 21) 61600890 Tel;(86 21) 61060889/Fax;(86 21) 61600890 关于西安瑞联新材料股份有限公司 2021 年限制性股票激励计划授予价格调整 及作废部分已授予尚未归属的限制性股票相关事项之 法律意见书 编号：君泽君[2025]证券字 2025-026-1-1 致：西安瑞联新材料股份有限公司 北京市君泽君（上海）律师事务所接受西安瑞联新材料股份有限公司（以下简称"瑞 联新材 ...

Group 1 - The core point of the news is that Ruilian New Materials (SH 688550) held its second board meeting for the fourth session on October 30, 2025, to discuss the appointment of the auditing firm for the fiscal year 2025 [1] - For the fiscal year 2024, the company's revenue composition is entirely from the manufacturing of chemical raw materials and chemical products, accounting for 100.0% [1] - As of the report date, Ruilian New Materials has a market capitalization of 8.5 billion yuan [1]

Core Points - The company announced that Ningbo Guofu Yongyu Venture Capital Partnership (Limited Partnership) reduced its shareholding by 514 shares, representing 0.0003% of the total share capital [1] - After this transaction, the enterprise holds 8,678,766 shares, with its ownership percentage decreasing from 5.0003% to 5.0000% [1] - Over the past six months, the enterprise has cumulatively reduced its shareholding by 5,630,285 shares, accounting for 3.2437% of the total share capital [1] - This change in equity will not result in a change of the company's controlling shareholder or actual controller [1]

Financial Performance - The company's operating revenue for Q3 2025 reached CNY 495,110,791.99, representing a year-on-year increase of 23.78%[3] - Total profit for the period was CNY 133,813,133.39, up 29.04% compared to the same quarter last year[3] - Net profit attributable to shareholders was CNY 114,738,292.99, reflecting a growth of 27.52% year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 31.57% to CNY 113,807,032.13[3] - Basic earnings per share for the quarter were CNY 0.66, a rise of 26.92% from the previous year[3] - The company reported a net profit margin improvement, with net profit for the first three quarters of 2025 expected to show a positive trend compared to the previous year[17] - The company's net profit for the current period reached CNY 280,813,491.12, a significant increase of 51.5% compared to CNY 185,303,402.44 in the previous period[18] - Operating profit increased to CNY 322,632,728.60, up from CNY 213,500,757.41, reflecting a growth of 51.1%[18] - The total revenue from operating activities was CNY 1,140,118,890.67, up from CNY 925,131,936.19, representing a growth of 23.2%[22] - The company reported a total comprehensive income of CNY 281,190,477.76, compared to CNY 185,298,819.49, an increase of 51.7%[19] - Basic and diluted earnings per share were both CNY 1.63, up from CNY 1.06, reflecting a growth of 53.8%[19] Assets and Liabilities - The company's total assets increased by 6.43% to CNY 3,616,208,949.88 compared to the end of the previous year[4] - Current assets as of September 30, 2025, totaled RMB 2,055,711,603.59, compared to RMB 1,815,877,383.47 at the end of 2024, reflecting a growth of 13.2%[14] - Cash and cash equivalents increased to RMB 714,467,161.06 from RMB 666,028,670.85, representing a rise of 7.2%[14] - Accounts receivable rose to RMB 322,415,788.96, up from RMB 235,048,911.33, indicating a growth of 37.2%[14] - Inventory decreased to RMB 461,592,216.37 from RMB 485,143,763.67, showing a decline of 4.9%[14] - Total liabilities as of September 30, 2025, were RMB 372,033,134.47, slightly down from RMB 372,532,626.44 at the end of 2024[16] - Total equity increased to RMB 3,244,175,815.41 from RMB 3,025,336,707.36, reflecting a growth of 7.2%[16] - Non-current assets totaled RMB 1,560,497,346.29, a slight decrease from RMB 1,581,991,950.33 at the end of 2024[15] Cash Flow and Expenses - The net cash flow from operating activities for the year-to-date was CNY 279,171,725.98, down 11.85% compared to the previous year[3] - Cash flow from operating activities generated a net amount of CNY 279,171,725.98, down from CNY 316,717,598.70, a decrease of 11.8%[22] - The cash and cash equivalents at the end of the period totaled CNY 419,100,460.49, down from CNY 521,405,156.24, a decrease of 19.6%[23] - Investment activities resulted in a net cash outflow of CNY 142,466,823.39, compared to a net inflow of CNY 45,932,456.22 in the previous period[23] - The company experienced a decrease in cash flow from financing activities, with a net outflow of CNY 101,721,811.94 compared to CNY 172,246,374.87 in the previous period[23] Research and Development - Research and development expenses totaled CNY 34,326,191.03, accounting for 6.93% of operating revenue, a decrease of 3.29 percentage points[4] - Research and development expenses amounted to CNY 93,617,861.06, compared to CNY 89,795,800.41, indicating a year-over-year increase of 4.5%[18] Revenue Growth - The company reported a significant increase in revenue from the pharmaceutical and electronic materials sectors, contributing to overall profit growth[7] - Total operating revenue for the first three quarters of 2025 reached RMB 1,301,339,713.58, an increase of 19.0% compared to RMB 1,093,434,243.13 in the same period of 2024[17] - Total operating costs for the first three quarters of 2025 amounted to RMB 971,685,463.94, up from RMB 873,358,217.18 in the first three quarters of 2024[17] Return on Equity - The return on equity (ROE) rose by 2.67 percentage points to 8.95% year-to-date[4]

证券代码：688550 证券简称：瑞联新材 公告编号：2025-088 西安瑞联新材料股份有限公司 关于为公司及公司董事、高级管理人员 1、投保人：西安瑞联新材料股份有限公司 2、被保险人：公司及公司董事、高级管理人员（具体以公司与保险公司协 商确定的范围为准） 3、赔偿限额：不低于人民币 5,000.00 万元（具体以保险合同为准） 4、保费支出：不超过人民币 20.00 万元/年（具体以保险合同为准） 5、保险期限：1 年，保险期满可续保或者重新投保 二、授权事项 购买责任险的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为进一步完善西安瑞联新材料股份有限公司（以下简称"公司"）的风险管 理体系、降低公司运营风险，促进公司董事、高级管理人员在各自职责范围内充 分行使权利、履行职责，保障公司董事、高级管理人员的权益，根据《上市公司 治理准则》《上市公司独立董事管理办法》等相关法律、法规的有关规定，公司 拟为公司及全体董事、高级管理人员购买责任保险（以下简称"董高责任险"）。 公司于 2025 年 10 月 30 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担个别及连带责任。 ● 拟聘任的会计师事务所名称：中汇会计师事务所（特殊普通合伙）（以下 简称"中汇会计师事务所"） ● 原聘任的会计师事务所名称：致同会计师事务所（特殊普通合伙）（以下 简称"致同会计师事务所"） 证券代码：688550 证券简称：瑞联新材 公告编号：2025-087 西安瑞联新材料股份有限公司 关于聘任公司 2025 年度审计机构的公告 ● 变更会计师事务所的简要原因及前任会计师的异议情况：鉴于完成公司 2024 年度审计工作后，致同会计师事务所已连续 4 年为公司提供审计服务。为 保证审计工作的独立性、客观性，基于审慎原则，同时考虑公司业务需要，公司 拟变更 2025 年度审计机构为中汇会计师事务所（特殊普通合伙）。公司已就本次 变更会计师事务所事项与致同会计师事务所进行充分沟通，致同会计师事务所对 本次变更事项无异议。 一、拟聘任会计师事务所的基本情况 | 2024 年（经审计） | 业务收入总额 | 10.14 亿元 | | --- | --- | --- | | ...

西安瑞联新材料股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 证券代码：688550 证券简称：瑞联新材 公告编号：2025-085 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 投资者可于 2025 年 10 月 29 日（星期三）至 11 月 4 日（星期二）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目提问或将有关问题通 过电子邮件的形式发送至公司投资者关系邮箱 securities@xarlm.com 进行提 问，公司将在说明会上对投资者普遍关注的问题进行回答。 西安瑞联新材料股份有限公司（以下简称"公司"）将于 2025 年 10 月 31 日披露公司《2025 年第三季度报告》，为便于广大投资者更全面深入地了解公司 2025 年第三季度的经营成果和财务状况，公司计划于 2025 年 11 月 5 日（星期 三）上午 11:00-12:00 举行 2025 年第三季度业绩说明会，就投资者关心的问题进 行交流。 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将 ...

Core Viewpoint - The company has a high proportion of foreign sales, accounting for approximately 70% of its revenue, and maintains stable relationships with international clients despite global trade conflicts [1] Group 1: Sales and Revenue - The company's foreign sales constitute about 70% of its total revenue [1] - Major markets for the company's sales include Germany, Japan, and South Korea [1] Group 2: Client Relationships - The company primarily serves a concentrated customer base, mainly consisting of foreign enterprises [1] - The company has established long-term cooperative relationships with internationally renowned clients, which helps ensure revenue stability [1] Group 3: Impact of Trade Conflicts - The company has experienced minimal impact from global trade conflicts in recent years [1] - The strong commercial reputation of its clients contributes to the stability of revenue and payment collection [1]